serious condition immune

Vasculitis in Dogs: Causes, Signs & Treatment

Vasculitis is blood vessel inflammation in dogs that causes skin lesions, ear tip necrosis, and organ damage. Learn causes, diagnosis, and treatment options.

Last updated Mar 12, 2026 8 min read

Vasculitis is a serious condition. Early detection changes outcomes.

Get Longevity Score
Vasculitis in dogs — veterinary care context
Severity Level Serious
Typical Onset
Can occur at any age; some breed-associated forms appear in young adults while drug- or infection-triggered vasculitis can develop at any life stage
Breeds Affected
5
Preventable
Not directly
Supplements Help
Limited
Puppy Longevity Editorial Team Veterinary-informed condition reference Reviewed Mar 2026

Evidence deep dives for Vasculitis

Pair mechanism-level evidence with practical protocol context before discussing next steps with your veterinarian.

The Ear Tips That Started Dying

Your Greyhound comes home from a boarding stay and you notice the tips of her ears look wrong — crusted, dark, and curling at the edges. Within a week, the tissue at the margins turns black and begins to slough. The rest of her seems fine, which makes the dying ear tips even more confusing. What you are seeing is tissue starved of blood supply, because the tiny vessels feeding those extremities have been destroyed by her own immune system.

Vasculitis is inflammation of blood vessel walls. When small blood vessels become inflamed and damaged, they can no longer deliver adequate blood flow to the tissues they supply. The result is ischemia (inadequate oxygen delivery), tissue necrosis (cell death), and a range of clinical signs that depend on which vessels — and which organs — are affected.

In dogs, vasculitis is not a single disease but a reaction pattern with many possible triggers. The inflammation can be immune-mediated (the body’s own immune system attacking vessel walls), triggered by infections, caused by adverse drug reactions, or associated with underlying cancers. In many cases, the specific cause is never identified, and the condition is classified as idiopathic vasculitis.

What makes vasculitis diagnostically challenging is its ability to mimic almost anything. Skin lesions can look like infections, frostbite, or allergic reactions. Internal organ involvement can present as kidney disease, GI bleeding, or neurological dysfunction. The protean nature of vasculitis means it often sits on the differential diagnosis list but requires biopsy confirmation to be definitively diagnosed.

Mechanisms of Vessel Damage

Understanding the underlying immunopathology helps explain the clinical patterns.

Type III hypersensitivity (immune complex deposition): The most common mechanism. Circulating immune complexes — antibodies bound to antigens from infections, drugs, or tumor proteins — deposit in small vessel walls and activate complement, attracting neutrophils that damage the vessel from within. This is similar to the mechanism seen in systemic lupus erythematosus.

Type II hypersensitivity (direct antibody-mediated): Antibodies bind directly to vessel wall components, activating complement and destroying the endothelial lining.

Infectious vasculitis: Certain pathogens directly invade and damage blood vessels. Rocky Mountain spotted fever (Rickettsia rickettsii) is one of the most recognized examples, along with some viral and fungal infections.

Drug-induced vasculitis: Reactions to vaccines, antibiotics, NSAIDs, or other medications can trigger vasculitis. The temporal relationship between drug administration and onset of signs is the key diagnostic clue.

The resulting vessel damage follows a predictable pattern: endothelial injury leads to thrombosis (clot formation within the vessel), leukocyte infiltration of the vessel wall, vessel wall necrosis, and ultimately tissue ischemia downstream of the damaged vessel.

Clinical Presentation

Vasculitis manifests differently depending on the size and location of affected vessels. Cutaneous (skin) vasculitis is the most commonly recognized form, but internal organ involvement occurs and can be more dangerous.

Skin signs (most visible and most commonly diagnosed):

  • Purpura: dark red-purple, non-blanching spots on the skin, especially on the ears, lips, footpads, and tail tip
  • Ear tip necrosis: crusting, curling, and progressive tissue loss at the ear margins (a classic vasculitis pattern)
  • Footpad ulceration and cracking
  • Skin ulcers, particularly on dependent areas and pressure points
  • Pitting edema of the limbs
  • Well-demarcated areas of skin necrosis (sharp borders between healthy and dead tissue)

Systemic signs (when internal vessels are affected):

  • Fever, lethargy, and decreased appetite
  • Joint swelling and pain (vasculitis affecting synovial vessels)
  • Blood in urine, stool, or vomit (GI or urinary tract vessel involvement)
  • Difficulty breathing (pulmonary vasculitis)
  • Neurological signs including seizures, head tilt, or behavioral changes (CNS vasculitis)
  • Peripheral edema and swelling

Breed-specific patterns:

  • Greyhounds and Italian Greyhounds: Cutaneous vasculitis affecting the thighs, particularly after vaccination or stress
  • Jack Russell Terriers: Familial cutaneous vasculopathy affecting footpads and ear tips in puppies
  • Rottweilers: Oral mucosal and cutaneous vasculitis
  • Dachshunds: Vaccine-associated vasculitis affecting dorsal skin

The Diagnostic Process

Skin biopsy: The gold standard for diagnosing vasculitis. Histopathology reveals characteristic changes: infiltration of vessel walls by inflammatory cells (neutrophils, lymphocytes, or eosinophils depending on the type), fibrinoid necrosis of vessel walls, and evidence of thrombosis. Multiple biopsies from affected areas increase diagnostic yield.

Supporting diagnostics:

  • CBC: may reveal thrombocytopenia, leukocytosis, or anemia
  • Chemistry panel: assesses kidney and liver function if internal involvement is suspected
  • Urinalysis with UPC ratio: screens for kidney vasculitis
  • ANA test: to evaluate for SLE as an underlying cause
  • Infectious disease screening: tick panels, fungal testing based on geography and exposure
  • Drug history review: timeline comparison between medication administration and symptom onset
  • Coagulation testing: if DIC is suspected

Treatment

Treatment targets the underlying cause when identified, combined with immunosuppressive therapy to control the inflammatory vessel destruction.

Immunosuppressive therapy:

  • Prednisone/prednisolone: First-line immunosuppression at anti-inflammatory to immunosuppressive doses (1-2 mg/kg/day), tapered based on response
  • Pentoxifylline: A methylxanthine that improves blood flow through damaged vessels and has anti-inflammatory properties; often used as a steroid-sparing agent or adjunct for cutaneous vasculitis (10-15 mg/kg two to three times daily)
  • Dapsone: Used for some neutrophilic vasculitis cases; requires regular CBC monitoring for hemolytic side effects
  • Mycophenolate or azathioprine: For cases requiring long-term steroid-sparing immunosuppression

Cause-specific treatment:

  • Infectious triggers: appropriate antimicrobial therapy (doxycycline for rickettsial disease, antifungals for mycotic vasculitis)
  • Drug-induced: immediate discontinuation of the offending agent
  • Tumor-associated: treatment of the underlying malignancy

Supportive care:

  • Wound management for necrotic skin lesions
  • Pain management (vasculitis is painful)
  • Limb wraps for edematous extremities
  • Nutritional support if appetite is compromised

12-Week Management and Monitoring Plan

  • Weeks 1-2 (initiation): Start immunosuppressive therapy, biopsy lesions if not yet done, initiate cause investigation. Photograph all lesions for baseline comparison. Begin daily tracking of lesion size, new lesion development, energy, and appetite.
  • Weeks 3-4 (early response): Most vasculitis shows measurable improvement within 2-3 weeks of appropriate treatment. Recheck bloodwork. If no response, reconsider diagnosis or add a second immunosuppressive agent.
  • Weeks 5-6 (taper consideration): If lesions are healing and no new lesions are forming, begin cautious steroid taper while maintaining pentoxifylline.
  • Weeks 7-8 (monitoring for relapse): The taper period is when flares are most likely. Any new lesion development should prompt a return to the previous effective dose.
  • Weeks 9-10 (sustained control): Continue taper. Recheck bloodwork. Assess whether steroid-sparing agents can maintain control alone.
  • Weeks 11-12 (long-term planning): Establish the minimum effective maintenance regimen. Many dogs with idiopathic vasculitis require low-dose long-term therapy to prevent relapse.

Feeding and Nutritional Considerations

  • Dogs on corticosteroids need caloric management to prevent obesity
  • Omega-3 fatty acids may support endothelial health and modestly reduce inflammation
  • Ensure adequate protein intake to support wound healing in dogs with skin necrosis

For guidance:

When to Go to the ER Today

  • Rapid spread of skin necrosis or new large areas of purpura
  • Blood in stool, vomit, or urine with progressive weakness
  • Severe limb swelling with pain and inability to walk
  • Collapse, seizures, or acute neurological changes
  • High fever (above 104 F / 40 C) with worsening lethargy
  • Signs of DIC: spontaneous bleeding from multiple sites

Vasculitis affecting internal organs can escalate unpredictably. Visible skin signs often underestimate the extent of systemic involvement.

Deeper Dives Into the Science

Frequently Asked Questions

Is vasculitis curable?

When a specific underlying cause is identified and removed (e.g., a drug reaction or infection), vasculitis can resolve completely. Idiopathic vasculitis often requires long-term immunosuppressive therapy and may wax and wane over months to years.

Can vasculitis be caused by vaccines?

Yes. Post-vaccination vasculitis is a documented adverse reaction, most commonly presenting as skin lesions at or near the injection site, or ear tip and extremity involvement weeks after vaccination. This does not mean vaccination should be avoided — the risk is low and the benefits of core vaccination far outweigh this rare side effect — but the temporal relationship should be noted and reported.

Is vasculitis painful?

Yes. Ischemic tissue damage is painful. Dogs with active vasculitis often show signs of discomfort including reluctance to walk, sensitivity to touch over affected areas, and appetite loss. Appropriate pain management should be part of the treatment plan.

Will the necrotic skin heal?

Mild cases with superficial vessel involvement heal well once inflammation is controlled. Severe cases with deep tissue necrosis may require debridement and extended wound care. Ear tip tissue lost to necrosis does not regenerate.

Can vasculitis affect internal organs without visible skin signs?

Yes. Internal vasculitis can involve the kidneys, GI tract, lungs, or CNS without any cutaneous manifestation. This makes diagnosis more challenging and usually requires biopsy of the affected organ.

Medical Disclaimer

This content is educational and does not replace veterinary diagnosis or treatment. Dogs with unexplained skin necrosis, purpura, ear tip lesions, or signs of multi-organ disease need prompt veterinary evaluation including biopsy confirmation.

References

  • Nichols PR et al. Cutaneous vasculitis in dogs: a retrospective study of 12 cases. J Am Anim Hosp Assoc. 2001;37(3):207-216.
  • Morris DO. Ischemic dermatopathy in dogs. Vet Clin North Am Small Anim Pract. 2013;43(1):99-111.
  • Innera M. Cutaneous vasculitis in small animals. Vet Clin North Am Small Anim Pract. 2013;43(1):113-134.
  • Scott DW et al. Muller and Kirk’s Small Animal Dermatology. 7th ed. Elsevier Saunders; 2013.
  • Gross TL et al. Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis. 2nd ed. Blackwell; 2005.

Related Reading

Continue exploring